{{Rsnum
|rsid=799908
|Gene=NBR2
|Chromosome=17
|position=43126899
|Orientation=plus
|GMAF=0.444
|Gene_s=BRCA1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{PharmGKB
|RSID=rs799908
|Name_s=BRCA1: -2004A>G
|Gene_s=NBR2, BRCA1
|Feature=
|Evidence=PubMed ID:18782836
|Annotation=This variant is in the promoter region of BRCA1 and has been shown to alter promoter acitivity in luciferase assay.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162370345
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs799908
|overall_frequency_n=40
|overall_frequency_d=90
|overall_frequency=0.444444
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}